Foundation Medicine climbs after $106M IPO


Save Story
Leer en espaƱol

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW YORK (AP) - Shares of Foundation Medicine surged Wednesday after the company's initial public offering raised $106 million before expenses.

Foundation Medicine said expanded its IPO to 5.9 million shares and said the offering priced at $18 per share. It had expected to sell 5 million shares for $14 to $16 each.

In midday trading the stock jumped $13.50, or 75 percent, to $31.50 after rising as high as $33.25 earlier. The shares are trading on the Nasdaq Global Select Market under the ticker symbol "FMI."

Foundation Medicine offers diagnostic cancer analyses that provide patient specific data for physicians. The company is based in Cambridge, Mass.

The underwriters of the IPO will have the option to buy another 883,333 shares.

(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Most recent Business stories

Related topics

Business

STAY IN THE KNOW

Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

KSL Weather Forecast